Greentank Secures USD $20 Million Strategic Investment from AIR Global PLC to Accelerate R&D Capabilities and Manufacturing Footprint

TORONTO, ON — July 2026 — Greentank Innovations Corp. (“Greentank”), a global pioneer in advanced vaporization hardware and material science, today announced the closing of a USD $20 million strategic equity investment from AIR Global PLC (“AIR”) (NASDAQ: AIIR), a world leader in advanced flavored inhalation technologies.

The investment, made at a pre-money valuation of approximately USD $170 million, expands upon the strategic partnership established between Greentank and AIR in 2023. As part of the agreement, AIR secures a warrant with the option to increase its equity stake by up to 20% over the next 24 months at a valuation of USD $250 million. The transaction includes enhanced commercial terms, long-term supply commitments, access to next-generation technologies, and board representation.

The capital will directly accelerate Greentank’s growth trajectory, enabling the company to scale its fully owned and operated, semi-automated chip manufacturing facilities, advance its deep-tech R&D pipeline, and expand the global deployment of its proprietary Quantum Chip™ atomization platform.

Pioneering the Next Generation of Inhalation Science

Greentank’s flagship Quantum Chip™ platform represents a monumental shift away from legacy ceramic and wire-coil heating technologies. Engineered at a molecular level, the chip technology delivers precise thermal regulation, optimized aerosol mass, and superior taste consistency across a variety of liquid formulations.

The strategic investment coincides with promising preliminary scientific validation of Greentank’s technology. In an independent pilot study conducted by McKinney Specialty Labs, LLC, aerosol generated by AIR’s Crown Switch™ vape, a device powered by Greentank’s Quantum Chip™ platform, demonstrated significantly reduced levels of harmful and potentially harmful constituents (HPHCs) compared to published data on FDA-authorized vape devices and traditional combustible cigarettes.

Key study highlights for Crown Switch aerosol included:

• Carbon Monoxide: Below detection limits across all tested formulations and power settings.
• Heavy Metals & Volatiles: Arsenic, cadmium, chromium, lead, nickel, benzene, and 1,3-butadiene were predominantly non-detectable or below limits of quantification.
• HPHC Reductions: Significantly reduced levels of carbonyls (including acetaldehyde and formaldehyde) compared to FDA-authorized benchmark vaping devices.

“This capital injection and expanded strategic partnership with AIR validate both the commercial viability and scientific foundation of our Quantum Chip™ platform,” said Corey Koffler, CEO and Co-Founder of Greentank. “When we developed our microchip heating technology, our goal was to redefine what’s possible in vaporization, delivering unprecedented aerosol consistency and performance while driving reduced-risk innovations across global markets. This funding enables us to rapidly scale our semi-automated manufacturing, broaden our patent portfolio, and solidify Greentank’s position as the hardware engine powering the future of the inhalation industry.”

Fueling Infrastructure, R&D, and Global Commercial Scale

With a robust patent portfolio dating back to 2014, Greentank has built a dominant presence across legal cannabis, nicotine, and wellness vaporization hardware categories. The funding will focus on three core strategic pillars:

1. Manufacturing Automation & Scale: Expanding capacity at Greentank’s specialized chip manufacturing facility to meet growing volume demands from tier-one global brands.
2. Material Science & IP Acceleration: Advancing proprietary microchip heating designs, micro-fluidic controls, and next-generation substrate formulations.
3. Global Market Footprint: Strengthening supply agreements and commercialization pathways across North America, Europe, and emerging global markets.

For more information about Greentank, its Quantum Chip™ platform, and advanced product solutions, visit www.greentanktech.com.

About Greentank

Greentank is a cutting-edge technology company pioneering atomization and advanced material science across multiple industries. At the forefront of innovation, Greentank’s Quantum Chip™ technology is engineered to deliver a superior user experience while advancing reduced-risk solutions in the inhalable industry. This groundbreaking heating technology generates optimal particle size distribution and aerosol mass, ensuring exceptional taste and consistency over an extended lifespan. Supported by a robust patent portfolio dating back to 2014, Greentank continues to invest heavily in its fully owned and operated, semi-automated chip manufacturing and R&D facility, driving the future of vaporization products and technology. 

Learn more at www.greentanktech.com.

About AIR Global PLC

Founded in 1999 and headquartered in Dubai, AIR (NASDAQ: AIIR) is a global consumer brands and innovation company with a presence in more than 90 markets worldwide. Its portfolio reaches millions of adult consumers across social inhalation and modern nicotine categories through brands including Al Fakher, Crown Switch, Crown Gems, and Al Fakher nicotine pouches.

Media & Investor Contact:

Email: inquiries@greentanktech.com

Phone: +1 (800) 935-1399

Website: www.greentanktech.com